Filing Details
- Accession Number:
- 0001091925-11-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-08 14:58:33
- Reporting Period:
- 2011-08-05
- Filing Date:
- 2011-08-08
- Accepted Time:
- 2011-08-08 14:58:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1091925 | L Thomas Kempner | C/O Loeb Partners Corporation 61 Broadway New York NY 10006 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-05 | 20,000 | $1.40 | 1,163,233 | No | 4 | P | Indirect | Trust (1) |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Trust (1) |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,308,810 | Indirect | Loeb Holding Corporation (2) |
Common Stock | 53,764 | Indirect | Loeb Investors Co. IX (3) |
Common Stock | 5,021 | Indirect | Spouse |
Common Stock | 11,792 | Indirect | Pinpoint Partners Corporation (4) |
Common Stock | 27,311 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $2.09 | 2021-05-21 | 75,000 | 75,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-05-21 | 75,000 | 75,000 | Direct |
Footnotes
- Such option will become exercisable in thirty-six (36) substantially equal installments on each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated) for a period of thirty-five (35) months, with the 36th monthly installment to become exercisable as of the commencement of business on the date of the Annual Meeting of Stockholders at which such director is up for reelection or at which such director's term ends.